Corticosteroid Treatment and Growth Patterns in Ambulatory Males with Duchenne Muscular Dystrophy-Reference-Cited by-同舟云学术

Corticosteroid Treatment and Growth Patterns in Ambulatory Males with Duchenne Muscular Dystrophy

Published:2016-06 Issue: Volume:173 Page:207-213.e3
ISSN:0022-3476
Container-title:The Journal of Pediatrics
language:en
Short-container-title:The Journal of Pediatrics

Author:

Lamb Molly M.,West Nancy A.,Ouyang Lijing,Yang Michele,Weitzenkamp David,James Katherine,Ciafaloni Emma,Pandya Shree,DiGuiseppi Carolyn,Cunniff Chris,Meaney John,Andrews Jennifer,Pettit Kathleen,Pettygrove Sydney,Miller Lisa,Matthews Dennis,Montgomery April,Donnelly Jennifer,Bolen Julie,Street Natalie,Lyles Bobby,Mann Sylvia,Romitti Paul,Mathews Katherine,Caspers Conway Kristin,Puzhankara Soman,Foo Florence,Pandya Shree,Westfield Christina,Druschel Charlotte,Campbell Kim,Fox Deborah

Funder

Centers for Disease Control and Prevention

Publisher

Elsevier BV

Subject

Pediatrics, Perinatology and Child Health

Reference47 articles.

1. Corticosteroid treatment and functional improvement in Duchenne muscular dystrophy: long-term effect;Balaban;Am J Phys Med Rehabil,2005

2. Intermittent prednisone therapy in Duchenne muscular dystrophy: a randomized controlled trial;Beenakker;Arch Neurol,2005

3. Long-term benefits of deflazacort treatment for boys with Duchenne muscular dystrophy in their second decade;Biggar;Neuromuscul Disord,2006

4. The cooperative international neuromuscular research group Duchenne natural history study: Glucocorticoid treatment preserves clinically meaningful functional milestones and reduces rate of disease progression as measured by manual muscle testing and othe

5. Deflazacort in Duchenne dystrophy: study of long-term effect;Angelini;Muscle Nerve,1994

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Is endocrine surveillance important in the care of Duchenne Muscular Dystrophy? Results from a national survey to patients and families on endocrine complications;eNeurologicalSci;2024-09

2. Disease-associated comorbidities, medication records and anthropometric measures in adults with Duchenne muscular dystrophy;Neuromuscular Disorders;2024-08

3. The use of the drug ataluren for the treatment of patients with Duchenne muscular dystrophy in real clinical practice;L.O. Badalyan Neurological Journal;2024-07-31

4. BREATHE DMD: boosting respiratory efficacy after therapeutic hypoxic episodes in Duchenne muscular dystrophy;The Journal of Physiology;2024-06-04

5. Gait classification for growing children with Duchenne muscular dystrophy;Scientific Reports;2024-05-11